Boeing (BA) opened Tuesday's trading action as the stronger performer in the SPX. Diane King Hall points to commentary from the company on returning to positive free cash flow lifting the plane manufa
Beacon Pointe Advisors LLC trimmed its position in Eli Lilly and Company (NYSE: LLY) by 43.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commis
Eli Lilly (LLY) said Monday that it's lowering the price of its popular weight-loss drug Zepbound, about a month after striking a deal with the Trump administration to lower drug costs.
Eli Lilly on Monday said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect.
The calendar flipped to December with investors hoping the market's most reliable month delivers again as several S&P 500 stocks show decades of strong seasonal gains.
Eli Lilly and Co (NYSE:LLY) said on Monday it is lowering the cash prices of its weight-loss drug Zepbound, marking the latest move in a growing price battle with rival Novo Nordisk. The US pharmaceut
Shares of Eli Lilly and Co (NYSE:LLY) are sliding into the red, down 0.8% to trade at $1,066.96 at last check, amid news the pharma giant cut prices on popular weight loss drug Zepbound.
Eli Lilly is cutting prices again for those who pay cash for introductory doses of the weight-loss drug Zepbound. The lowest dose vial will cost $299 a month, that would be a saving of about $50.
Stock futures are sliding as December trading gets underway and investors parse through Bitcoin's (BTC) pullback
Eli Lilly cut prices for Zepbound on its direct-to-consumer platform. The Nasdaq Composite is coming off a losing month amid AI spending concerns.
Eli Lilly said on Monday it has lowered the price of single-dose vials of its popular obesity drug Zepbound to make the treatment more affordable for U.S. patients, as demand for weight-loss therapies
Eli Lilly said it is lowering the cash prices of single-dose vials of its blockbuster weight loss drug Zepbound on its direct-to-consumer platform, LillyDirect. Starting Dec. 1, cash-paying patients w
Brentview Investment Management LLC boosted its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 38.7% during the second quarter, according to the company in its most recent disclosure with
Boston Family Office LLC increased its holdings in shares of Eli Lilly and Company (NYSE: LLY) by 71.1% in the second quarter, according to the company in its most recent Form 13F filing with the Secu
Both of these stocks are growing by leaps and bounds. MercadoLibre boasts a cohesive ecosystem that is driving revenue and profits forward.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE